Whereas CD47 is expressed abundantly on LSC in a constitutive manner in most patients with AML and most with CML, the expression of PD-L1 is often weak or absent on LSC in these malignancies. Here, CD274 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.